O	0	10	Behavioral
O	11	14	and
O	15	28	psychological
O	29	35	impact
O	36	38	of
O	39	48	returning
O	49	55	breast
O	56	63	density
O	64	71	results
O	72	74	to
B-ethinicity	75	82	Latinas
O	82	83	:
O	84	89	study
O	90	98	protocol
O	99	102	for
O	103	104	a
O	105	115	randomized
O	116	124	clinical
O	125	130	trial
O	130	131	.

O	132	138	Breast
O	139	145	cancer
O	146	148	is
O	149	152	the
O	153	157	most
O	158	164	common
O	165	171	cancer
O	172	175	and
O	176	179	the
O	180	187	leading
O	188	193	cause
O	194	196	of
O	197	203	cancer
O	204	213	mortality
O	214	219	among
O	220	227	Latinas
O	227	228	.

O	229	231	As
O	232	236	more
O	237	239	is
O	240	247	learned
O	248	253	about
O	254	257	the
O	258	269	association
O	270	277	between
O	278	290	mammographic
O	291	297	breast
O	298	305	density
O	306	307	(
O	307	310	MBD
O	310	311	)
O	312	315	and
O	316	322	breast
O	323	329	cancer
O	330	334	risk
O	334	335	,
O	336	337	a
O	338	344	number
O	345	347	of
O	348	349	U
O	349	350	.
O	350	351	S
O	351	352	.
O	353	359	states
O	360	367	adopted
O	368	379	legislation
O	380	383	and
O	384	387	now
O	388	389	a
O	390	397	federal
O	398	401	law
O	402	410	mandates
O	411	418	written
O	419	431	notification
O	432	434	of
O	435	438	MBD
O	439	444	along
O	445	449	with
O	450	459	mammogram
O	460	467	results
O	467	468	.

O	469	474	These
O	475	488	notifications
O	489	493	vary
O	494	496	in
O	497	504	content
O	505	508	and
O	509	520	readability
O	520	521	,
O	522	528	though
O	528	529	,
O	530	535	which
O	536	539	may
O	540	545	limit
O	546	551	their
O	552	565	effectiveness
O	566	569	and
O	570	576	create
O	577	586	confusion
O	587	589	or
O	590	597	concern
O	597	598	,
O	599	609	especially
O	610	615	among
O	616	621	women
O	622	626	with
O	627	630	low
O	631	637	health
O	638	646	literacy
O	647	649	or
O	650	658	barriers
O	659	661	to
O	662	671	screening
O	671	672	.

O	673	676	The
O	677	684	purpose
O	685	687	of
O	688	692	this
O	693	698	study
O	699	701	is
O	702	704	to
O	705	714	determine
O	715	722	whether
B-intervention	723	734	educational
I-intervention	735	746	enhancement
I-intervention	747	749	of
I-intervention	750	753	MBD
O	754	766	notification
O	767	774	results
O	775	777	in
O	778	787	increased
O	788	797	knowledge
O	797	798	,
O	799	808	decreased
O	809	816	anxiety
O	816	817	,
O	818	821	and
O	822	831	adherence
O	832	834	to
O	835	844	continued
O	845	856	mammography
O	857	866	screening
O	867	872	among
B-eligibility	873	879	Latina
I-eligibility	880	885	women
I-eligibility	886	888	in
I-eligibility	889	890	a
I-eligibility	891	898	limited
I-eligibility	898	899	-
I-eligibility	899	908	resources
I-eligibility	909	916	setting
O	916	917	.

O	918	925	Latinas
O	926	934	LEarning
O	935	940	About
O	941	948	Density
O	949	950	(
O	950	955	LLEAD
O	955	956	)
O	957	959	is
O	960	961	a
O	962	972	randomized
O	973	981	clinical
O	982	987	trial
O	988	989	(
O	989	992	RCT
O	992	993	)
O	994	1003	comparing
O	1004	1007	the
O	1008	1014	impact
O	1015	1017	of
O	1018	1023	three
O	1024	1036	notification
O	1037	1047	approaches
O	1048	1050	on
O	1051	1061	behavioral
O	1062	1065	and
O	1066	1079	psychological
O	1080	1088	outcomes
O	1089	1091	in
O	1092	1098	Latina
O	1099	1104	women
O	1104	1105	.

O	1106	1119	Approximately
B-total-participants	1120	1124	2000
B-eligibility	1125	1132	Latinas
I-eligibility	1133	1143	undergoing
I-eligibility	1144	1153	screening
I-eligibility	1154	1165	mammography
I-eligibility	1166	1168	in
I-eligibility	1169	1170	a
I-eligibility	1171	1177	safety
I-eligibility	1177	1178	-
I-eligibility	1178	1181	net
I-eligibility	1182	1191	community
I-eligibility	1192	1198	clinic
O	1199	1203	will
O	1204	1206	be
O	1207	1217	randomized
O	1218	1219	1
O	1219	1220	:
O	1220	1221	1
O	1221	1222	:
O	1222	1223	1
O	1224	1226	to
B-control	1227	1233	mailed
I-control	1234	1246	notification
I-control	1247	1248	(
I-control	1248	1253	usual
I-control	1254	1258	care
I-control	1258	1259	)
O	1259	1260	;
O	1261	1267	mailed
O	1268	1280	notification
O	1281	1285	plus
O	1286	1293	written
O	1294	1305	educational
O	1306	1315	materials
O	1316	1317	(
O	1317	1325	enhanced
O	1325	1326	)
O	1326	1327	;
O	1328	1330	or
O	1331	1337	mailed
O	1338	1350	notification
O	1350	1351	,
O	1352	1359	written
O	1360	1371	educational
O	1372	1381	materials
O	1381	1382	,
O	1383	1387	plus
O	1388	1394	verbal
O	1395	1406	explanation
O	1407	1409	by
O	1410	1411	a
O	1412	1421	promotora
O	1422	1423	(
O	1423	1436	interpersonal
O	1436	1437	)
O	1437	1438	.

O	1439	1442	The
O	1443	1454	educational
O	1455	1464	materials
O	1465	1468	and
O	1469	1475	verbal
O	1476	1488	explanations
O	1489	1492	are
O	1493	1502	available
O	1503	1505	in
O	1506	1513	Spanish
O	1514	1516	or
O	1517	1524	English
O	1524	1525	.

O	1526	1536	Mechanisms
O	1537	1544	through
O	1545	1550	which
O	1551	1558	written
O	1559	1561	or
O	1562	1568	verbal
O	1569	1580	information
O	1581	1591	influences
O	1592	1598	future
O	1599	1608	screening
O	1609	1619	motivation
O	1620	1623	and
O	1624	1632	behavior
O	1633	1637	will
O	1638	1640	be
O	1641	1649	examined
O	1649	1650	,
O	1651	1653	as
O	1654	1658	well
O	1659	1661	as
O	1662	1672	moderating
O	1673	1680	factors
O	1681	1685	such
O	1686	1688	as
O	1689	1699	depression
O	1700	1703	and
O	1704	1709	worry
O	1710	1715	about
O	1716	1722	breast
O	1723	1729	cancer
O	1729	1730	,
O	1731	1736	which
O	1737	1741	have
O	1742	1746	been
O	1747	1753	linked
O	1754	1756	to
O	1757	1767	diagnostic
O	1768	1774	delays
O	1775	1780	among
O	1781	1788	Latinas
O	1788	1789	.

O	1790	1793	The
O	1794	1799	study
O	1800	1808	includes
O	1809	1817	multiple
O	1818	1831	psychological
O	1832	1840	measures
O	1841	1842	(
O	1842	1849	anxiety
O	1849	1850	,
O	1851	1861	depression
O	1861	1862	,
O	1863	1872	knowledge
O	1873	1878	about
O	1879	1882	MBD
O	1882	1883	,
O	1884	1893	perceived
O	1894	1898	risk
O	1899	1901	of
O	1902	1908	breast
O	1909	1915	cancer
O	1915	1916	,
O	1917	1922	worry
O	1922	1923	,
O	1924	1928	self
O	1928	1929	-
O	1929	1937	efficacy
O	1937	1938	)
O	1939	1942	and
O	1943	1953	behavioral
O	1954	1962	outcomes
O	1963	1964	(
O	1964	1973	continued
O	1974	1983	adherence
O	1984	1986	to
O	1987	1998	mammography
O	1998	1999	)
O	1999	2000	.

O	2001	2012	Measurement
O	2013	2017	time
O	2018	2024	points
O	2025	2032	include
O	2033	2043	enrollment
O	2043	2044	,
O	2045	2046	2
O	2046	2047	-
O	2047	2048	4
O	2048	2049	â
O	2049	2050	€
O	2050	2051	‰
O	2051	2056	weeks
O	2057	2061	post
O	2061	2062	-
O	2062	2075	randomization
O	2075	2076	,
O	2077	2080	and
O	2081	2082	1
O	2083	2086	and
O	2087	2088	2
O	2089	2094	years
O	2095	2099	post
O	2099	2100	-
O	2100	2113	randomization
O	2113	2114	.

O	2115	2126	Qualitative
O	2127	2134	inquiry
O	2135	2142	related
O	2143	2145	to
O	2146	2153	process
O	2154	2157	and
O	2158	2166	outcomes
O	2167	2169	of
O	2170	2173	the
O	2174	2187	interpersonal
O	2188	2191	arm
O	2192	2195	and
O	2196	2200	cost
O	2201	2209	analysis
O	2210	2217	related
O	2218	2220	to
O	2221	2224	its
O	2225	2239	implementation
O	2240	2244	will
O	2245	2247	be
O	2248	2258	undertaken
O	2259	2261	to
O	2262	2272	understand
O	2273	2276	the
O	2277	2289	intervention
O	2289	2290	'
O	2290	2291	s
O	2292	2300	delivery
O	2301	2304	and
O	2305	2320	transferability
O	2320	2321	.

O	2322	2333	Legislation
O	2334	2343	mandating
O	2344	2351	written
O	2352	2355	MBD
O	2356	2368	notification
O	2369	2372	may
O	2373	2377	have
O	2378	2388	unintended
O	2389	2401	consequences
O	2402	2404	on
O	2405	2415	behavioral
O	2416	2419	and
O	2420	2433	psychological
O	2434	2442	outcomes
O	2442	2443	,
O	2444	2456	particularly
O	2457	2462	among
O	2463	2470	Latinas
O	2471	2475	with
O	2476	2483	limited
O	2484	2490	health
O	2491	2499	literacy
O	2500	2503	and
O	2504	2513	resources
O	2513	2514	.

O	2515	2519	This
O	2520	2525	study
O	2526	2529	has
O	2530	2542	implications
O	2543	2546	for
O	2547	2553	cancer
O	2554	2558	risk
O	2559	2572	communication
O	2573	2576	and
O	2577	2581	will
O	2582	2587	offer
O	2588	2596	evidence
O	2597	2599	on
O	2600	2603	the
O	2604	2613	potential
O	2614	2616	of
O	2617	2630	generalizable
O	2631	2642	educational
O	2643	2653	strategies
O	2654	2657	for
O	2658	2668	delivering
O	2669	2680	information
O	2681	2683	on
O	2684	2690	breast
O	2691	2698	density
O	2699	2701	to
O	2702	2709	Latinas
O	2710	2712	in
O	2713	2720	limited
O	2720	2721	-
O	2721	2729	resource
O	2730	2738	settings
O	2738	2739	.

O	2740	2754	ClinicalTrials
O	2754	2755	.
O	2755	2758	gov
O	2758	2759	,
O	2760	2771	NCT02910986
O	2771	2772	.

O	2773	2783	Registered
O	2784	2786	on
O	2787	2789	21
O	2790	2799	September
O	2800	2804	2016
O	2804	2805	.

O	2806	2811	Items
O	2812	2816	from
O	2817	2820	the
O	2821	2824	WHO
O	2825	2830	Trial
O	2831	2843	Registration
O	2844	2848	Data
O	2849	2852	Set
O	2853	2856	can
O	2857	2859	be
O	2860	2865	found
O	2866	2868	in
O	2869	2873	this
O	2874	2882	protocol
O	2882	2883	.
